Have Insiders Sold Aura Biosciences Shares Recently?

Investors may wish to note that the Chief Technology Officer of Aura Biosciences, Inc., Mark Plavsic, recently netted US$77k from selling stock, receiving an average price of US$6.35. On the bright side, that's just a small sale and only reduced their holding by 5.8%.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Aura Biosciences Insider Transactions Over The Last Year

In the last twelve months, the biggest single purchase by an insider was when Chief Financial & Business Officer Anthony Gibney bought US$245k worth of shares at a price of US$4.90 per share. Although we like to see insider buying, we note that this large purchase was at significantly below the recent price of US$5.67. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.

Over the last year, we can see that insiders have bought 70.00k shares worth US$343k. But they sold 86.59k shares for US$679k. In total, Aura Biosciences insiders sold more than they bought over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

See our latest analysis for Aura Biosciences

If you are like me, then you will not want to miss this free list of small cap stocks that are not only being bought by insiders but also have attractive valuations.

Does Aura Biosciences Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Our data indicates that Aura Biosciences insiders own about US$6.0m worth of shares (which is 1.6% of the company). Overall, this level of ownership isn't that impressive, but it's certainly better than nothing!

So What Does This Data Suggest About Aura Biosciences Insiders?

An insider sold Aura Biosciences shares recently, but they didn't buy any. Zooming out, the longer term picture doesn't give us much comfort. When you consider that most companies have higher levels of insider ownership, we're a little wary. So we'd only buy after very careful consideration. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. Case in point: We've spotted 3 warning signs for Aura Biosciences you should be aware of, and 1 of them is a bit unpleasant.

Of course Aura Biosciences may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.